ICD-10 Coding for Polysubstance Dependence(F19.10, F19.10U, F19.20)
Comprehensive guide on ICD-10 coding for polysubstance dependence, including documentation requirements, coding pitfalls, and billing considerations.
Complete code families applicable to Polysubstance Dependence
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| F19.20 | Polysubstance dependence, uncomplicated | Use when the patient is dependent on three or more substances without specifying a predominant substance. |
|
| F19.21 | Polysubstance dependence, in remission | Use when the patient is in remission from dependence on three or more substances. |
|
| F19.24 | Polysubstance dependence with withdrawal | Use when the patient is experiencing withdrawal from dependence on three or more substances. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutPolysubstance Dependence
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Polysubstance Dependence.
Vague documentation of substance use
Impact
Clinical: Inadequate treatment planning, Regulatory: Potential audit issues, Financial: Reduced reimbursement
Mitigation
Use structured templates, Include specific substance details
Using F19.10 for dependence cases
Impact
Reimbursement: Incorrect coding may lead to lower reimbursement., Compliance: Non-compliance with ICD-10 guidelines., Data Quality: Inaccurate representation of patient condition.
Mitigation
Use F19.20 when dependence criteria are met for multiple substances.
Substance specificity
Impact
Lack of specificity in documenting substances can lead to audit findings.
Mitigation
Use detailed documentation templates that specify each substance.